We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
(-8.2%)
Cap. Flow
-$614M
Cap. Flow
% of AUM
-16.42%
Top 10 Holdings %
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$113M |
| 2 |
Intel
INTC
|
+$61.2M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$25.3M |
| 4 |
Clorox
CLX
|
+$25.2M |
| 5 |
TJX Companies
TJX
|
+$24.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$107M |
| 2 |
Apple
AAPL
|
+$71.8M |
| 3 |
Travelers Companies
TRV
|
+$27.6M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$27.4M |
| 5 |
American Express
AXP
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.7% |
| 2 | Financials | 10.88% |
| 3 | Technology | 9.76% |
| 4 | Communication Services | 9.34% |
| 5 | Consumer Staples | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMCS
151
DELISTED
P M C SIERRA INC
PMCS
| $5.58M | 0.15% |
+480,000
| New | +$5.44M |
|
152
The Mosaic Company
MOS
$7.09B
| $5.54M | 0.15% |
200,815
+21,391
| +12% | +$683K |
|
|
RDUS
153
DELISTED
Radius Health, Inc.
RDUS
| $5.54M | 0.15% |
90,000
-14,400
| -14% | -$909K |
|
154
Travel + Leisure Co
TNL
$4.54B
| $5.5M | 0.15% |
167,589
-323,266
| -66% | -$11.2M |
|
155
iShares US Real Estate ETF
IYR
$4.59B
| $5.48M | 0.15% |
72,900
| – | – |
|
156
GameStop
GME
$9.5B
| $5.47M | 0.15% |
780,848
+26,436
| +4% | +$255K |
|
157
Alnylam Pharmaceuticals
ALNY
$36.3B
| $5.37M | 0.14% |
57,000
-5,400
| -9% | -$501K |
|
158
CNX Resources
CNX
$4.85B
| $5.31M | 0.14% |
+806,839
| New | +$5.7M |
|
159
Franklin Resources
BEN
$16.9B
| $5.3M | 0.14% |
143,834
+42,115
| +41% | +$1.65M |
|
|
GG
160
DELISTED
Goldcorp Inc
GG
| $5.29M | 0.14% |
459,779
+301,120
| +190% | +$3.83M |
|
161
Brown-Forman Class B
BF.B
$12B
| $5.29M | 0.14% |
166,484
+3,984
| +2% | +$133K |
|
162
RTX Corp
RTX
$287B
| $5.23M | 0.14% |
86,461
-67,594
| -44% | -$4.09M |
|
163
DTE Energy
DTE
$31.1B
| $5.22M | 0.14% |
76,444
+61,581
| +414% | +$4.24M |
|
164
Oracle
ORCL
$331B
| $5.21M | 0.14% |
142,676
-74,238
| -34% | -$2.84M |
|
165
Cummins
CMI
$91.7B
| $5.2M | 0.14% |
59,059
+50,347
| +578% | +$5.03M |
|
166
United Therapeutics
UTHR
$26.3B
| $5.18M | 0.14% |
33,100
-7,000
| -17% | -$1.02M |
|
167
Hewlett Packard
HPE
$63.2B
| $5.14M | 0.14% |
+582,166
| New | +$4.87M |
|
168
EQT Corp
EQT
$33.2B
| $5.11M | 0.14% |
179,927
+94,969
| +112% | +$3.19M |
|
169
Capri Holdings
CPRI
$1.77B
| $5.08M | 0.14% |
+126,763
| New | +$5.22M |
|
170
Exelixis
EXEL
$13.9B
| $5.08M | 0.14% |
900,000
-186,000
| -17% | -$1.04M |
|
|
SGEN
171
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.06M | 0.14% |
112,700
| – | – |
|
|
ICPT
172
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.05M | 0.14% |
33,800
-6,000
| -15% | -$1.02M |
|
173
Cigna
CI
$76.6B
| $4.99M | 0.13% |
34,108
+26,066
| +324% | +$3.58M |
|
174
Whirlpool
WHR
$2.42B
| $4.98M | 0.13% |
33,908
+3,100
| +10% | +$481K |
|
175
Delta Air Lines
DAL
$55.9B
| $4.93M | 0.13% |
+97,279
| New | +$4.81M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2015 Portfolio in Review
As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.
- Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
- Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
- Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
- Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
- Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
- Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
- Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.
Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.